EGFR and neoplasm: When the tumor volume reached 13.20 ± 2.51 mm3, CA-siRNA(s) against EGFR-1(50 nM) or EGFR-2 (50 nM) were given intravenously into the tail vein of mice at 3 days with a total of two injections.